Magenta Therapeutics (MGTA) PT Raised to $17 at Mizuho Securities
Tweet
Share
E-mailGet Alerts MGTA Hot Sheet
Price: $0.70 --0%
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
Mizuho Securities analyst Defei Yang raised the price target on Magenta Therapeutics (NASDAQ: MGTA) to $17.00 (from $16.00) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Danske Bank A/S (DANSKE:DC) (DNKEY) PT Raised to DKK340 at JPMorgan
- KBC Group (KBC:BB) (KBCSY) PT Raised to EUR117 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
